FLGT Q3 2018 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q3 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$6M+24.9% YoY

Gross Profit

$3M53.6% margin

Operating Income

-$846,000-15.0% margin

Net Income

-$595,000-10.6% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+4.2%

Cash Flow

Operating Cash Flow

-$105,000

Free Cash Flow

-$1M

Stock-Based Comp.

$588,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$2M

Stockholders' Equity

$53M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+24.9%
Gross Profit	$3M	$2M	+34.8%
Operating Income	-$846,000	-$1M	+42.9%
Net Income	-$595,000	-$1M	+45.6%

Geographic Segments

UNITED STATES

$3M58%

Other Countries

$1M21%

CANADA

$1M20%

CHINA

$23,0000%